INTRODUCTION
Monosodium glutamate (MSG) is sodium salt of naturally occurring non-essential L form of glutamic acid, it is one of the main flavor enhancers which is widely used in the preparation of large percentage of canned, frozen and prepared foods, especially soups, sauces and broths (1,2) . Recently, monosodium glutamate consumption has increased throughout the world as flavoring in cooking and to increase palatability and food selection in a meal (3, 4) . The use of MSG has been steadily increasing worldwide over the past years, somehow paralleling the rising incidence of the metabolic syndrome and fatty liver disease (5) . Human cerebral cortical activity may be under the influence of a large number of neuroactive substances, These substances are important for the normal integrity of the normal function of the CNS system which controls a variety of physiological, behavioral, and endocrinal function (6) . Glutamic acid is the most abundant of a group of endogenous amino acids in the mammalian central nervous system and has become widely accepted as a major neurotransmitter in the vertebrate central nervous system (7) . L Glutamate is the major excitatory neurotransmitter in the brain, exists in the extracellular fluid only in very small concentrations, and clearly plays a pivotal role in the formation of synapses and neuronal circuitry, in neuronal differentiation, migration and survival in the developing brain (8, 9) . Glutamate receptors are present in the central nervous system, mouth, lungs, intestines, muscle, and other "peripheral" locations. Brains have many receptors for glutamic acid (10,11) . In the brain it is an important mediator of sensory information, motor coordination, emotions and cognition including formation and retrieval of the memory and adaptation to the environment (12,13) .
GABA is the principal inhibitory neurotransmitter in the mammalian central nervous system. GABAergic pathways sub-serve a variety of functions, including regulation of brain excitability, modulation of respiratory neural inputs, motor control, and information processing within and between brain regions (14,15) . MSG has neurotoxic effects resulting in brain cell damage, retinal degeneration, endocrine disorders and some pathological conditions such as stroke, epilepsy, neuropathic pain, schizophrenia, anxiety, depression and degenerative disorders (16) . Although MSG was reported to have broad toxic effects interestingly little is known about the effects of MSG added to dry food on oxidative stress and metabolic parameters (17, 18) . Oxidative stress represents an imbalance between the production and the effects of reactive oxygen species and a biological system's ability to readily detoxify the reactive intermediates or to repair the resulting damage (19) . So, the present study was conducted to elucidate the effect of oral ingestion of monosodium glutamate on some biochemical changes in the brain and blood of experimental rats as it is widely used as flavor enhancer.
MATERIALS & METHODS
This study was carried out on 50 female white albino rats (weight 200-250 grams) that were divided into two equal groups; Group I (control group), which were given a standard diet for 45 days and group II, which were given a standard diet and monosodium glutamate (MSG) orally by gastric tube in a dose of (0.4 g/kg body weight) for 45 days. The doses of MSG were chosen on the basis of the previous studies (20) . All experiments were carried out according to the guidelines of the Ethical Committee of Tanta University, Faculty of Medicine.
Sample collection:
All rats were sacrificed and blood samples were collected. Sera were separated and stored in aliquots at -70 ○ C till used for different estimations. Then, the abdomen and the thorax were opened; visceral fats were dissected, washed with saline and weighed. The brains were removed carefully, washed three times in ice cold saline to remove extraneous materials, blotted individually on ashfree filter paper, and then divided into two specimens. Specimens were stored at -70 ºC till used for preparation of tissue homogenates. Preparation of brain tissue homogenates:
Specimens were weighted and homogenized with a PotterElvenhjem tissue homogenizer (20-30 up and down strokes). One part was homogenized in ice-cold saline and centrifuged at 10,000 rpm for 10 minutes at 0°C for estimation of Lglutamate and gamma amino butyric acid (GABA) levels and the second was homogenized in potassium phosphate buffer 10 mM (pH 7.4) and centrifuged at 7,700 x g for 30 minutes at 4°C for estimation of malondialdehyde (MDA) level, Homogenate was centrifuged at 7,700 x g at 4 o C for 30 minutes and the resultant supernatant was assayed for the different estimations. 
RESULTS

Fig. 2:
Comparison between the two studied groups as regards body weight (g). Table 1 showed a state of dyslipidemia with significant increase of serum triacylglycerol, total cholesterol and LDL-cholesterol (P < 0.001) and significant decrease of serum HDL-C level in MSG treated group (group II) as compared to group I (P < 0.001). Table ( 2) and figures (1) showed comparison between the two studied groups as regards glucose tolerance test. Significantly higher plasma glucose levels during fasting and the following four samples after the glucose load were noticed in rats of group II compared to their levels in group I (P<0.05 for each). Table ( 3) and figures (2) showed comparison between body weight (g) of the two studied groups starting from the initial weight to their weight at 6 weeks separated by 2 weeks interval. There was significant increase of body weight by the end of 6 th weeks in group II compared to group I (P<0.001). Also, there was significant increase of visceral fat weight in group II compared to group I (P<0.001), table (4). Both serum FFAs (mmol/l.) and MDA (nmol/ml) levels showed significant increase in group II compared with its level in group I (P<0.001), table (5).
In the present study, brain tissues showed significant increase of MDA as well as L. glutamate (P < 0.001)and significant decrease (P<0.001), of GABA levels in group II as compared to group I, table (5).
Correlation studies in the present study showed significant positive correlation between brain MDA level and brain L. glutamate level (r = 0.652, P < 0.001) .Negative correlation was found between both MDA and GABA brain tissue levels (r = -0.558, p < 0.001). Negative correlation was found between brain GABA level and brain L. glutamate level in MSG treated group (r = -0.756, P < 0.001). Also there was positive correlation between both serum and brain MDA levels in MSG treated group (r = 0.815, P < 0.001), and also between body weight and visceral fat weight in MSG treated group (r = 0.877, P < 0.001). The present study also showed a state of dyslipidemia in MSG treated group with significant increase of serum levels of total cholesterol, triacylglycerol and LDL-C and significant decrease of HDL-C level. Also, serum free fatty acids (FFAs) level showed significant increase in MSG-treated rats when compared to control group.
DISCUSSION
These results are in harmony with those obtained by Zhang et al.
(33) , Singh et al.
(36) and Sasaki et al.
who found that oral ingestion of MSG induces a state of dyslipidemia with significant increase of serum levels of total cholesterol, triacylglycerol, LDL-C ,VLDL-C, free fatty acids and significant decrease of HDL-C. The present study also showed significant increase of total body and visceral fat weights in MSG treated group as compared to the control group. These results are in harmony with other previous studies of Nagata et al.
(30) and Sasaki et al.
(32) who reported significant increase of total body weight and BMI of MSG-treated mice compared with the normal mice, although food intake was equal. They documented that the main cause of obesity was not thought to be a disturbance of appetite, suggesting that obesity is caused by a decrease in energy metabolism, secondary to brown adipose tissue (37) and autonomic nerve dysfunction (38) . Dolnikof et al. (39) proposed that the presence of an enhanced insulin sensitivity in MSG rats is responsible for the decreased lipolytic activity and enhanced glucose uptake. In addition, the enhanced lipogenesis and glycerol reutilization seen in their adipose tissue disturbs the normal balance between fat depots breakdown and accumulation in favor of the latter. Thus, the massive accumulation of adipose tissue in those animals seems to be related to an imbalance between the signals which control both the lipolytic response and the lipogenic activity.
Similarly, Sasaki et al.
and Matyšková et al. (40) reported that all mice with MSG obesity excessively accumulated subcutaneous, abdominal and gonadal fat and showed dramatically enhanced fat and body weight.
Luz et al. (41) reported that neonatal administration of monosodium glutamate to rodents leads to appearance of obesity in the adult animals, which is usually characterized by a significant increase in body fat. They have suggested that MSG induced obesity could be the result of a decreased metabolic rate rather than of increased food intake.
In addition, Baculikova et al.
(42)
and Matyšková et al. (40) reported that the administration of MSG to newborn rats causes the destruction of the ventromedial hypothalamic and arcuate nuclei, leading the rats to develop obesity that results from the lack of control between absorption and energy expenditure. The real mechanism by which this hypothalamic injury leads to obesity is not known, but what is known is that it is not because of increased food intake (40) . Afifi et al.
(43) also concluded that MSG treated pregnant rats, in spite of mild hypophagia, showed severe increase in fat/ body weight ratio. Moreover, maternal obesity in pregnancy, caused by MSG, has greater impact on offspring metabolism. They suggested that the relationship between MSG-induced damage of arcuate nucleus and the metabolic changes that produce obesity at mild hypophagia be probably occurred due to the lack of leptin receptors in arcuate nucleus and the development of leptin resistance.
Also, Collison et al.
(44) stated that MSG increased the expression of several genes implicated in adipocytes differentiation.
Induction of oxidative stress as a consequence of MSG treatment had been also reported by Onyema et al. (45) . Lipid peroxidation in cellular membranes damages polyunsaturated fatty acids tending to reduce membrane fluidity, which is essential for proper functioning of the cell. MDA, an end-product of LPO induced by reactive oxygen species (ROS), is well correlated with the degree of lipid peroxidation (46) . When lipid peroxides are formed in some organs or tissues and accumulated to certain degree, they leak from organs or tissues into the blood stream and increase lipid peroxides level in serum or the plasma. Although an increased lipid peroxides level in blood can be due to either exogenous causes or endogenous ones, an abnormal increase in lipid peroxides level is usually due to the latter, which indicates the occurrence of tissue damage in cells of some organs or tissues provoked by the diseases or xenobiotics (46,47) . This study showed significant increase in both serum and brain malondialdehyde (MDA) levels in MSG-treated rats confirming the effect of MSG in induction of oxidative stress.
The brain contains large amounts of polyunsaturated fatty acids (PUFA), which are particularly vulnerable to free radical attacks resulting in the formation of carbon and hydroxyl radicals (48) . The latter initiates a chain reaction, ultimately generating numerous toxic reactants that rigidify membranes by crosslinking, disrupting membrane integrity and changing membrane proteins (48,49) .
The significant increase in serum and brain MDA levels observed in MSG-treated groups in the present study is in agreement with the results of Pavlovic et al. (51) who reported an increased the serum MDA level, a marker of lipid peroxidation in MSG-treated rats by over two-folds, which may be due to the increased generation of reactive oxygen species (ROS) by MSG.
Farombi et al.,
also documented that a significant induction of lipid peroxidation in the liver, kidney and brain of rats treated with MSG might be due to oxidative stress induced by MSG in those tissues.
Brain L-Glutamate level in the present study showed significant increase in MSG-treated rats compared to the control group, a finding which is in agreement with the results of Manivasagam and Subramanian (53) who found significant increase in the brain Lglutamate level of rats treated with MSG.
López-Pérezet et al.
(54) also reported that MSG administration prompts an immediate increase of cerebral glutamate tissue level and also elevates glutamate extracellular levels in plasma and other tissues, where the amount reached depends on administration pathway, doses, age and the animal model used.
The pharmacokinetics of MSG depends on its route of administration which, in turn determine its effects on extracellular brain glutamate concentrations. When glutamate is consumed orally, its effects on the brain are buffered by metabolism in the gastrointestinal tract. Extrusion from the brain by active blood-brain transport systems, and local mechanisms mediating its uptake and metabolism in brain; these cause brain extracellular glutamate concentrations to remain relatively stable. The mechanism of MSG neurotoxic effects has been attributed to a prolonged increase in extracellular glutamate concentrations (55) . Similarly, under normal conditions, the glutamate carrier through the blood-brain barrier (BBB) is virtually saturated at physiological plasma glutamate concentrations (56) . Moreover, in physiological conditions the influx of glutamate across the BBB is much lower than its efflux from the brain (57) . Therefore, the increase in plasma glutamate levels after systemic MSG administration may not by itself cause the increase in extracellular brain glutamate levels. This increase may also reflect damage to mechanisms operating at the level of the BBB; increased permeability after systemic MSG resulting from the massive increase in plasma osmolarity (58) .
Our study also showed significant decrease of brain gamma amino butyric acid (GABA) level in MSGtreated rats. This finding is in agreement with the result of Sepúlveda et al.
(59) who reported that MSG neurotoxicity reduces the activity of glutamic acid decarboxylase (GAD) in some areas of the CNS and, consequently, the content of GABA.
CONCLUSION
On the basis of these results it could be concluded that oral monosodium glutamate used as a food additive may be an inductive factor of several biochemical and metabolic alterations, which clearly must contribute to the development of obesity, impaired glucose tolerance and some excitotoxic effects.
RECOMMENDATIONS
The present findings are alarming, and throw doubts upon the unscrupulousness of current use of the flavoring agent MSG in fast processed and canned foods. Much work is still to be performed to determine other adverse effects on other organs. 
